Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity

Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity

US Patent 9988444 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

General amyloid interaction motif (GAIM)2025
Humanized and affinity-matured anti-CEACAM1 antibodies2024
Antibody specific for CD22 and methods of use thereof2024
Antibody specific for CD22 and methods of use thereof2024
Anti-kit antibodies and uses thereof2024
Anti-kit antibodies and uses thereof2024
Anti-MET antibodies and methods of use thereof2024
Anti-MET antibodies and methods of use thereof2024
Anti-MET antibodies and methods of use thereof2024
Humanized antibodies against CEACAM12024
Humanized antibodies against CEACAM12024
Humanized antibodies against CEACAM12024